Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02189655

Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
China Medical University, China · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.

Detailed description

This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.Group Control:traditional intrathecal administration; Group Diluting:Diluting with cerebrospinal fluid

Conditions

Interventions

TypeNameDescription
PROCEDUREbupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluidHyperbaric bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid was administered intrathecally in 30 seconds

Timeline

Start date
2016-03-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2014-07-14
Last updated
2019-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02189655. Inclusion in this directory is not an endorsement.

Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects (NCT02189655) · Clinical Trials Directory